Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva To Expand Presence In India

This article was originally published in PharmAsia News

Executive Summary

LUCKNOW, UTTAR PRADESH, INDIA - Israeli pharmaceutical company Teva Pharmaceutical will invest more than $1 billion in India over the next two years to establish greenfield manufacturing facilities and acquire Indian drug companies, said a Jan. 10 report in the local newspaper Business Standard.
Advertisement

Related Content

U.S. Court Dismisses Teva’s Patent Infringement Plea Against Dr Reddy’s Carvedilol; Dr Reddy’s May Launch Drug Soon
U.S. Court Dismisses Teva’s Patent Infringement Plea Against Dr Reddy’s Carvedilol; Dr Reddy’s May Launch Drug Soon
Dr Reddy’s Earnings Plunge On German Unit Charge, Increased Generic Competition
Dr Reddy’s Earnings Plunge On German Unit Charge, Increased Generic Competition
Teva To Invest Billion In India Acquisitions, New Facility
Advertisement
UsernamePublicRestriction

Register

SC066706

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel